| Product Code: ETC4471742 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sepsis Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sepsis Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Sepsis Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Sepsis Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United States (US) Sepsis Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United States (US) Sepsis Diagnostics Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 United States (US) Sepsis Diagnostics Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.9 United States (US) Sepsis Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 United States (US) Sepsis Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Sepsis Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of sepsis cases in the US |
4.2.2 Rising awareness about the importance of early sepsis detection and diagnosis |
4.2.3 Technological advancements in sepsis diagnostics leading to improved accuracy and efficiency |
4.3 Market Restraints |
4.3.1 High cost associated with sepsis diagnostic tests and procedures |
4.3.2 Lack of skilled healthcare professionals for accurate sepsis diagnosis |
4.3.3 Regulatory challenges and stringent approval processes for new sepsis diagnostic technologies |
5 United States (US) Sepsis Diagnostics Market Trends |
6 United States (US) Sepsis Diagnostics Market, By Types |
6.1 United States (US) Sepsis Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Blood Culture, 2021 - 2031F |
6.1.4 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Immunoassays, 2021 - 2031F |
6.1.5 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Molecular Diagnostics, 2021 - 2031F |
6.1.6 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Flow Cytometry, 2021 - 2031F |
6.1.7 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Microfluidics, 2021 - 2031F |
6.1.8 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Biomarkers, 2021 - 2031F |
6.2 United States (US) Sepsis Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Blood Culture Media, 2021 - 2031F |
6.2.3 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Assays & Reagents, 2021 - 2031F |
6.2.4 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Instruments, 2021 - 2031F |
6.2.5 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Software, 2021 - 2031F |
6.3 United States (US) Sepsis Diagnostics Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Automated Diagnostics, 2021 - 2031F |
6.3.3 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Conventional Diagnostics, 2021 - 2031F |
6.4 United States (US) Sepsis Diagnostics Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Bacterial Sepsis, 2021 - 2031F |
6.4.3 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Fungal Sepsis, 2021 - 2031F |
6.4.4 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Viral Sepsis, 2021 - 2031F |
6.4.5 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Other Pathogen, 2021 - 2031F |
6.5 United States (US) Sepsis Diagnostics Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Laboratory Tests, 2021 - 2031F |
6.5.3 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Point-of-Care Tests, 2021 - 2031F |
6.6 United States (US) Sepsis Diagnostics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Hospitals and specialty clinics, 2021 - 2031F |
6.6.3 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Pathology & Reference Laboratories, 2021 - 2031F |
6.6.4 United States (US) Sepsis Diagnostics Market Revenues & Volume, By Research Laboratories & Academic Institutes, 2021 - 2031F |
7 United States (US) Sepsis Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Sepsis Diagnostics Market Export to Major Countries |
7.2 United States (US) Sepsis Diagnostics Market Imports from Major Countries |
8 United States (US) Sepsis Diagnostics Market Key Performance Indicators |
8.1 Average turnaround time for sepsis diagnostic test results |
8.2 Adoption rate of new sepsis diagnostic technologies in healthcare facilities |
8.3 Percentage increase in early sepsis detection rates |
8.4 Number of research and development collaborations for improving sepsis diagnostics |
8.5 Rate of hospital readmissions due to sepsis-related complications |
9 United States (US) Sepsis Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Sepsis Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United States (US) Sepsis Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United States (US) Sepsis Diagnostics Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 United States (US) Sepsis Diagnostics Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.5 United States (US) Sepsis Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 United States (US) Sepsis Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Sepsis Diagnostics Market - Competitive Landscape |
10.1 United States (US) Sepsis Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sepsis Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here